chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First noticed tachycardia on 3/23/21, a few weeks after second dose which was on 2/19/21. In June 2021 was diagnosed with possible Afib by cardiologist, and then later diagnosed by an EP in December 2021. Prior to the vaccines I had no diagnosis of any cardio problems, and had not noticed any tachycardia.  After multiple tests, had a calcium score of 38 and a mildly dilated aortic root, and some moderate mitral regurgitation. Stress tests, regular and nuclear are normal. Am now taking a blood thinner and statin.
Within an hour after vaccines, pt experiencing urticaria concentration on face (with erythematous (B) ears) extremities and trunk. No lip/tongue edema but was clearing throat and coughing. She was not in resp. distress. 12/4 to clinic vitals S4O2 96% RR 22, BP 106/70. Given 12.5 mg Benadryl 5mg Zyrtec and observed.
Arm hurt a lot/Sore arm; Shivers/could not get warm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "Arm hurt a lot/Sore arm"; CHILLS (non-serious) with onset Mar2021, outcome "unknown", described as "Shivers/could not get warm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a female patient who on 11-SEP-2006 was vaccinated with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). The physician reported that within 24 hours of receiving the vaccine the patient developed a maculo papular rash all over the body. Medical attention was sought. The patient's outcome was unknown. Additional information has been requested.
Swelling, redness 6-8" on upper arm, which has progressed below her elbow. KEFLEX 500mg TID x 10 days & ice packs ordered R/T some lymphangitis.
DEVELOPED HIVES AT SITES OF HRIG INFILTRATION. DEVELOPED GENERALIZED HIVES FOLLOWING DAY AFTER OF VACCINATIONS (ALSO RECEIVED RABAVERT SAME DAY AS HRIG
7 Y.O. male inadvertently administered Pfizer 12+ dose instead of Pfizer 5-11 dose. Patient had no adverse symptoms from vaccination.
weltz appeared on waist, legs, shoulders, ankles, and all ten toes.  weltz were giving me a very itchy and burning sensation.  Two days later the weltz turned into rashes and im still dealing with the itching
Nurse callls and reports a dose of PROQUAD was inadvertently given via intramuscular route instead of subcutaneous; No other adverse events (AE) reported; This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender.  The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD),  lot number reported and validated as T037955, expiration date reported and validated as 09-MAY-2022, intramuscular as prophylaxis (vaccination scheme and site of administration was not reported) (subcutaneous injection formulation administered by other route). No adverse events were reported.
When I woke up at 4:00 am., I noticed the blanchiness and severe itching at the left upper arm with few small rashes. I also have itchiness in my body but no rashes.
The patient received SARS-CoV-2 (COVID-19) mRNA BNT-162b2 vaccine (COVID Vaccine ? Pfizer 30 mcg/0.3 mL).  The patient should have received the bivalent COVID vaccine booster.
Administered after the published expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after the published expiration date) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after the published expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered after the published expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  The vial was moved to fridge on the date of administration. The vial did not undergo temperature excursions. No adverse events reported by the patient after the administration error.  No treatment medication was provided.
Initial case received on 10 September 2010 from a healthcare professional. A "2 and 1/2" year old (2 years 11 months per date of birth) male patient received a right thigh intramuscular injection of FLUZONE SV 2010-2011 (lot number UH181AC) on 03 September 2010. The patient developed a persistent cough a few days after the vaccination. At an office visit on 09 September 2010, he was diagnosed with pneumonia with wheezing and bilateral rales. He was afebrile at that time. A chest x-ray was performed (date and results not reported). The patient had no illness at the time of the vaccination. He had no vaccinations within four weeks and no adverse events following prior vaccinations. He had no pre-existing medical conditions, allergies and no concomitant medications. The patient recovered on an unspecified date. Documents held by sender: None.
Information has been received from a nurse who talked to the mother of a 15 year old female patient with no pertinent medical history and no known drug allergies who on 18-MAR-2009 was vaccinated with the first dose of GARDASIL (lot# not provided). There was no concomitant medication. On approximately 18-APR-2009 ("a month after receiving the first dose of GARDASIL") the patient experienced rashes on her legs, headache, swollen glands, joint pain, dizziness, vomiting, nausea, she fainted at school a couple of times, redness and swelling at injection site, muscle aches and abdominal pain. Therapy with human papillomavirus vaccine was discontinued. Patient sought medical attention via a nurse practitioner and lab diagnostics tests were performed. At the time of this report, the patient had not recovered. Follow-up information has been received from a registered nurse who reported that the patient is white, weighs 122 pounds and is 64.25 inches tall. Patient had received the first dose of GARDASIL (lot# 661703/0651X) intramuscularly on the left deltoid. Patient also experienced fatigue and the syncope episode occurred on 23-SEP-2009. On 24-SEP-2009 patient had the following labs performed: CMC, BMP, TSH (results not provided). At the time of this report the patient's outcome was unknown. No further information is available.
Increased tiredness and low grade fever that over next 24 hours worsened.  Fever peaked at 105.8 F on 10/5/2009 at 6:00pm.
contracted covid after receiving second dose of vaccine; chills; aches; felt blah; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt blah), COVID-19 (contracted covid after receiving second dose of vaccine), CHILLS (chills) and MYALGIA (aches) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0131020A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (felt blah), CHILLS (chills) and MYALGIA (aches). On 14-May-2021, the patient experienced COVID-19 (contracted covid after receiving second dose of vaccine). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt blah), COVID-19 (contracted covid after receiving second dose of vaccine), CHILLS (chills) and MYALGIA (aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-132184 (Patient Link).
Left arm sore 2 days, 3rd day left neck, shoulder, arm , shoulder blade pain. Symptoms have not resolved 1/18/2021, not as painful now advil and massage therapist therapist treatment
A physician reported that a 3 year old female received FLUMIST vaccine in error. No adverse event was reported to have occurred at the time of this report. The reporter causality is not provided.
stomachache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomachache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomachache). At the time of the report, ABDOMINAL PAIN UPPER (stomachache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
First vaccine was given on 3/11/21 and 7 days later my left shoulder had a palm size rash around injection site.  After my 2nd dose 4/08, 12 hours later I had a fever, muscle ache, fatigue, swollen lymph nodes in neck and headache with  ringing in my left ear. By morning of 4/09 only the heachache and ringing of my ears remain as of 4/11. Will this go away? Should I see my PCP ?
Intense induration, erythema, tenderness to palpation occurring in the area circumscribing the anthrax vaccination area approx. 10 cm in diameter covering entire deltoid area, no fluctuance or signs of abscess. Pt provided Benadryl, given education, followed closely.  Site improved following day and resolved without further intervention necessary.  Two unplanned visits to clinic.  This was shot 3 of Anthrax series.  Pt never had any systemic symptoms and had not had this kind of a reaction prior to this one.
After about an hour after the dose there was face  (right cheek and upper lip) ?tremors?.  The nerve movements  in my face  were moving for about 3 hours
pt was given an expired vaccine due to immunization system having incorrect manufactures expiration date listed on site
ACUTE LEFT SIDED COSTOPHRENIC PAIN AND NAUSEA WITH RAPID DEVELOPMENT OF BILATERAL NUMBNESS WITH ATAXIA STARTING AT FEET RISING TO GROIN IMMEDIATELY.   NUMBNESS AND PARAPLEGIA  PERSISTED AND AROSE TO RIBS WITHIN 12 HOURS  TWO ER VISITS.   HOSPITALIZED AND MONITORED FOR FOUR DAYS  DX: ACUTE GUILLAIN-BARRE SYNDROME per NEUROLOGY Received 4 infusions of IViG.  1 infusion per day X 4 days.
Information has been received from a health professional concerning a 23 month old male, with no known medical history and allergies, who on 9/13/2004 was vaccinated with an intramuscular first dose in the right arm of varicella virus vaccine live (lot 0099F). It was reported that on 5/18/2005, at approximately 2:00pm, the patient developed an itchy rash that his mom just noticed today. There were no laboratory or diagnostic tests performed. Additional information is not expected.
This spontaneous report was received from a health care professional refers to a 7 month old patient of unknown gender. On 16-MAR-2016 the patient was inadvertently administered with the third dose of ROTATEQ which was expired with a lot # K004773; expiry: 22-FEB-2016 (dosing regimen unspecified). On an unknown date, previously patient was vaccinated with 2 doses of ROTATEQ. This was supported as per stability memo. No adverse effects reported. There was no product quality complaint involved. No further information provided.
administration of an expired vaccine with no reported adverse event; Initial information received on 12-Oct-2023 regarding an unsolicited valid  non-serious case received via other health professional.  This case involves a 54-year-old male patient and the reporter stated administration of an expired vaccine diphtheria-2/tetanus-5 adsorbed toxoids No preservative adult [Tenivac]with no reported adverse event.  The patient's past medical history included Injury NOS. The patient's past medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On 12-Oct-2023, the patient received a 0.5 ml total dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids No preservative adult, Suspension for injection (strength: unknown) (lot: U7183AA, expiry date: 24-Sep-2023) via intramuscular route in the left deltoid for immunization and administration of an expired vaccine with no reported adverse event (expired product administered) (latency: same day).  Action taken with diphtheria and tetanus toxoids (Tenivac) was not applicable.  Outcome: unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Lymphadenopathy on left neck. 800 mgs ibuprophen improved yesterday, today second lymph node inflammation.
Approximately 12 hours after injection,  injection site swollen with lump developed.  Patient experienced severe chills and a temperature of 101 degrees, a severe headache, swollen and painful joints, loss of smell, taste and severe fatigue.  Symptoms were severe for 36 hours and lowered to mild at 48 after injection.
Patient received Anthrax .5ml to right deltoid. Reported feeling a burning sensation to arm. Patient reported she was feeling faint. She was assisted to chair and proceeded to have a syncope episode. Patient was assisted with floor and legs/feet were elevated. The entire episode lasted approx. 30 sec. Patient regain consciousness and was oriented to person, place and situation. Patient released back to duty and reported feeling fine. She's had a previous episode in the past while receiving an injection reportedly to have been years ago as a child.
This spontaneous report has been received from a medical assistant and referred to an unknown number of patients of unknown ages and gender. The patients' relevant medical history, concurrent conditions, drug reactions/allergies, and concomitant therapies were not reported. On unknown dates, the unspecified patients were vaccinated with improperly stored doses of VARIVAX single dose, subcutaneously (strength and dose were not reported; lot number M039316 with an expiration date 20-SEP-2018) for prophylaxis that were reconstituted with properly stored sterile diluent single dose (lot number and expiration dates were not reported). The vaccine was exposed to a temperature range from 15°F to 46°F for a total time frame of 9 hours. There was no previous temperature excursion and no data logger measure was involved. No adverse effects were reported, and product quality complaint (PQC) was not involved. This is one of two reports from the same reporter. Additional information is not expected as there was no consent to contact the physician. Sender's Comments: US-009507513-1705USA014040.
Dizziness and left side pain/discomfort around chest area (5/10). Pt received 2 L of O2 via NC and 325 mg of ASA. Vitals stable. Pt did not take BP med today, pt agreed to take her Benicar 20mg when escorted to her car (med in car).
15 lesions appeared around hairline head & legs;lesions smaller than nl chicken pox lesions;fever x 2 days;lesions crusted over;
Severe pain began on top of my left foot in the evening( about 32 hours after receiving my Moderna second booster). I had only had Pfizer brand vaccines for my 3 previous vaccines. The pain felt like a piece of heavy machinery had been dropped on top of my foot. I was unable to bend the foot to flex it up or down within the hour and it began to rapidly swell. I had not injured my foot or bumped it since getting the vaccine (rested for 24 hours after getting the second booster). My husband who happens to be a physician examined it and said it was terrible swollen and bruised above the swelling. The pain was about a 9.5 on a scale of 1-10. I took Acetaminophen and iced it for an hour. The swelling was totally gone in the morning when I woke up and I had no pain whatsoever.
Extreme generalized joint and muscle pain lasting 5 days. No serious adverse events. I just felt the need to report the generalized severe pain.; Extreme generalized joint and muscle pain lasting 5 days. No serious adverse events. I just felt the need to report the generalized severe pain.; This is a spontaneous report from contactable nurse (patient). A 43-year-old female patient received her first dose of BNT162B2 (Lot number: EH9899), via an unspecified route of administration on 21Dec2020 05:30 at single dose (dose 1) in the left arm for COVID-19 immunization. Medical history included hypothyroid, migraine, depression and allergies: Sulfa. The patient's concomitant medications were not reported. On 22Dec2020 02:00, the patient experienced extreme generalized joint and muscle pain lasting days. No serious adverse events. She just felt the need to report the generalized severe pain. No treatment received for all the events. The outcome of the events was recovering.
Itchy scalp, forearms, upper back; went to ER and received Benadryl and Solumedrol, then got "ball in throat" and neck redness - received Epinephrine; all cleared in 2 hours
Patient received HEP A (HAVRIX) in left deltoid & ADACEL in right deltoid .  Became light headed, gave her whiff of ammonia inhalant, cold paper towel, sat for 15 minutes, her friend drove her home.  Pulse regular - color good, walked unassisted.
This spontaneous report as received from 2 healthcare workers refers to numerous unspecified patients. No demographic information was provided. PNEUMOVAX23 (lot number not provided) was exposed to 29-35 degrees Fahrenheit multiple times over a period of 3 months. The improper storage started on 29-DEC-2012. The improperly stored PNEUMOVAX23 was administered to numerous unspecified patients on unspecified dates. Reportedly PNEUMOVAX23 was "not supported by in-house stability data". No adverse event reported. This is one of several reports received from the same source (other case IDs 1306USA008658, 1307USA008944, 1307USA008946, 1307SUA008947, 1307USA008948 and 1307USA008949). Additional information has been requested.
VARICELLA and KINRIX administered 5:30 pm on 3-31-10. 4-1-10 redness, 4-2-10 AM arm still red, by PM temp. Child taken to same day care clinic, arm still red, swollen.
Pt received 4 year shots 8/2/04 returned to office 8/5/04 left leg very red and swollen approximately 1/4 of front of leg.
SOB, cough, soure throat. test COVID + prior to admission and during admission. Dexamethasone, Vit C and Zinc given. Out of window for remdisivir. O2 2L at admit, increased to 5L. Pt weaned to 3L by DC. Home with O2. sent home with dexamethasone.
tinnitus, severe fatigue, headaches, palpitations, blurry/double vision, brain fog, spaced out feeling.
When patient got home on 7/3/19 site was sore, redness, and warm to touch.  Contine to get bigger and 7/5/19 was the worst day. On 7/6/19 throat felt tight. Pt. seen in office on 7/8/19 and site was red, warm to touch. Measuring 9 cm across arm and  8 cm down the arm
associate began to complain of itching to right arm. BP 132/76 in left arm. 97.5 temperature. HR 80. Oxygen sat 95%; taken at 1434.  1445: discharged home.
Patient complained of throat tightness and swelling. Vital signs obtained. T 99.0 P 102 R 18 BP 151/105 O2 Sat 98%. DECADRON 4 mg and DEPO-MEDROL 40mg administered at 1256. Patient monitored until 1:50 pm. No complaints of throat tightness or difficulty breathing. Vitals at discharge P103 BP 143/89 O2 sat 97%.
Moderna Bivalent came from our central facility. On paperwork, beyond use date was labeled 4/5/23, but on bag that vaccine came in, beyond use date was labeled 5/15/23. Patient received vaccine on 4/21/23.  Clinical pharmacist checked with the manufacturer and determined the doses that were administered were valid.
Large, red, circular bump at the site of the injection. Was itchy when first notices but now feels fine; red circular bump is still visible though.
Started with pain in his ankles, that moved up his body over the course of a few hours. Severe HA, dizziness, and confusion. Followed by admission to the hospital from the ER. The initial dx was Guillian Barre syndrome, then changed to aseptic meningitis. 5 day hospital course. Patient continues to have neurological symptoms including severe HAs, weakness, and numbness in his left arm, and numbness on the bottom of both feet. He is being followed by a neurologist, and primary care physician.
Identified an adult patient received an adolescent dose of HEP B. Incident reported to our risk manager and patient's PCP informed. Reviewed consequences and next steps with our risk management team and pharmacy consultant. Reported event on VAERS, contacted patient and scheduled patient for appointment for the last HEP B dose.
pain and swelling at injection site.  5 days later, red mark in a circle kept expanding w/extreme itching and red hot to touch.  went to urgent care and got hydrocortisone
Systemic: eyesight was going out. blurred vision-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: after receive shot pt started to have blurred vision, tingling sweating, back pain. the vision wasnt coming back so we called the ambulance. she started to feel better. they check her vitals, everything fine. maybe having a panic attack
Within 10 min left ear was warm and itchy, slowly progressed to left sides of neck and face. Waited full 30 min with no change. EMT advised me to take Benadryl at home after checking for rash. No trouble breathing. On the drive home, my left tongue and mouth went numb and left tonsil swelled slightly. I took 2 benadryl at home and felt better a few hours later. No recurrence as of today. With my first dose of the vaccine, I only noticed immediate nasal drainage.